Cystatin C in cerebrospinal fluid and multiple sclerosis
- 1 August 2007
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 62 (2) , 193-196
- https://doi.org/10.1002/ana.20945
Abstract
Objective A recent study using surface‐enhanced laser desorption/ionization time‐of‐flight analysis of cerebrospinal fluid identified a 12.5kDa truncated isoform of cystatin C (CysC) as a specific biomarker for multiple sclerosis (MS). Methods Surface‐enhanced laser desorption/ionization time‐of‐flight analysis of cerebrospinal fluid samples from 43 MS patients and 46 healthy control subjects. Results Full‐length CysC (13.4kDa) concentration was similar in MS and control samples. The 12.5kDa CysC protein was produced from full‐length CysC by N‐terminal cleavage during storage at −20°C. Interpretation The 12.5kDa CysC isoform is a storage‐related artifact and is not useful as a diagnostic marker for MS. Ann Neurol 2007;62:193–196Keywords
This publication has 8 references indexed in Scilit:
- Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosisAnnals of Neurology, 2006
- Influences of Blood Sample Processing on Low–Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass SpectrometryClinical Chemistry, 2005
- Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?Proteomics, 2005
- Sample Handling for Mass Spectrometric Proteomic Investigations of Human SeraAnalytical Chemistry, 2005
- Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experimentsBioinformatics, 2004
- Proteomics: new perspectives, new biomedical opportunitiesThe Lancet, 2000
- Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controlsZeitschrift für Neurologie, 2000
- CLINICAL DIAGNOSTIC CRITERIA IN EPIDEMIOLOGICAL STUDIES OF MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965